The treatment of breast cancer cell lines with indole-3-carbinol, an anti-tumoral agent, is able to down-regulate TENM3 expression, which supports the possible role of TENM3 overexpression in tumor development [94]. This evidence concerns the gene TENM3 and neoplasm.